Literature DB >> 21193426

Vascular risk assessment in patients with sickle cell disease.

Claudia R Morris.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21193426      PMCID： PMC3012755          DOI： 10.3324/haematol.2010.035097

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  37 in total

1.  Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction.

Authors:  Katherine C Wood; Robert P Hebbel; David J Lefer; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2006-01-17       Impact factor: 7.376

2.  Pulmonary hypertension and NO in sickle cell.

Authors:  Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor R Gordeuk; Cheryl A Hillery; Gregory J Kato; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

Review 3.  Pulmonary hypertension and nitric oxide depletion in sickle cell disease.

Authors:  H Franklin Bunn; David G Nathan; George J Dover; Robert P Hebbel; Orah S Platt; Wendell F Rosse; Russell E Ware
Journal:  Blood       Date:  2010-04-15       Impact factor: 22.113

4.  Airway hyperresponsiveness in children with sickle cell anemia.

Authors:  Joshua J Field; Janet Stocks; Fenella J Kirkham; Carol L Rosen; Dennis J Dietzen; Trisha Semon; Jane Kirkby; Pamela Bates; Sinziana Seicean; Michael R DeBaun; Susan Redline; Robert C Strunk
Journal:  Chest       Date:  2010-08-19       Impact factor: 9.410

5.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

6.  Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Authors:  Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin
Journal:  Nat Med       Date:  2002-11-11       Impact factor: 53.440

7.  Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy.

Authors:  Angela Siciliano; Giorgio Malpeli; Orah S Platt; Christophe Lebouef; Anne Janin; Aldo Scarpa; Oliviero Olivieri; Eliana Amato; Roberto Corrocher; Yves Beuzard; Lucia De Franceschi
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

Review 8.  Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Authors:  Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood Rev       Date:  2006-11-07       Impact factor: 8.250

9.  Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.

Authors:  Gregory J Kato; Zeneng Wang; Roberto F Machado; William C Blackwelder; James G Taylor; Stanley L Hazen
Journal:  Br J Haematol       Date:  2008-03-17       Impact factor: 6.998

10.  Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.

Authors:  Victor R Gordeuk; Andrew Campbell; Sohail Rana; Mehdi Nouraie; Xiaomei Niu; Caterina P Minniti; Craig Sable; Deepika Darbari; Niti Dham; Onyinye Onyekwere; Tatiana Ammosova; Sergei Nekhai; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro
Journal:  Blood       Date:  2009-09-01       Impact factor: 22.113
View more
  13 in total

1.  Increased stroke size following MCA occlusion in a mouse model of sickle cell disease.

Authors:  Wei Luo; Enming Joseph Su; Jintao Wang; Hui Wang; Chiao Guo; Amrita Pawar; Andrew D Campbell; Daniel A Lawrence; Daniel T Eitzman
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

2.  Changes in Conjunctival Hemodynamics Predict Albuminuria in Sickle Cell Nephropathy.

Authors:  Ali Kord Valeshabad; Justin Wanek; Santosh L Saraf; Bruce I Gaynes; Victor R Gordeuk; Robert E Molokie; Mahnaz Shahidi
Journal:  Am J Nephrol       Date:  2015-08-05       Impact factor: 3.754

3.  Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.

Authors:  Tite Minga Mikobi; Prosper Tshilobo Lukusa; Michel Ntetani Aloni; Aimé Lumaka; Pierre Zalagile Akilimali; Koenraad Devriendt; Gert Matthijs; Jean-Marie Mbuyi Muamba; Valerie Race
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

4.  Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients.

Authors:  Salam Alkindi; Said S Almufargi; Anil Pathare
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

5.  Infrared imaging of nitric oxide-mediated blood flow in human sickle cell disease.

Authors:  Alexander M Gorbach; Hans C Ackerman; Wei-Min Liu; Joseph M Meyer; Patricia L Littel; Catherine Seamon; Eleni Footman; Amy Chi; Suzana Zorca; Megan L Krajewski; Michael J Cuttica; Roberto F Machado; Richard O Cannon; Gregory J Kato
Journal:  Microvasc Res       Date:  2012-07-08       Impact factor: 3.514

6.  Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.

Authors:  Claudia R Morris; Hae-Young Kim; Felicia Trachtenberg; John Wood; Charles T Quinn; Nancy Sweeters; Janet L Kwiatkowski; Alexis A Thompson; Patricia J Giardina; Jeanne Boudreaux; Nancy F Olivieri; John B Porter; Ellis J Neufeld; Elliott P Vichinsky
Journal:  Blood       Date:  2011-07-19       Impact factor: 22.113

7.  Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.

Authors:  Hui Wang; Wei Luo; Jintao Wang; Chiao Guo; Stephanie L Wolffe; Julia Wang; Eddy B Sun; Kori N Bradley; Andrew D Campbell; Daniel T Eitzman
Journal:  Br J Haematol       Date:  2013-04-17       Impact factor: 6.998

8.  Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation.

Authors:  Raffaella Colombatti; Elena Varotto; Silvia Ricato; Daniel Nardo; Nicola Maschietto; Simone Teso; Marta Pillon; Chiara Messina; Ornella Milanesi; Laura Sainati
Journal:  Hematol Rep       Date:  2011-09-01

9.  Sickle cell disease: looking back but towards the future.

Authors:  Rodolfo Delfini Cançado
Journal:  Rev Bras Hematol Hemoter       Date:  2012

10.  Conjunctival and pulmonary hemodynamic properties in sickle cell disease subjects with and without pulmonary hypertension.

Authors:  Ali Kord Valeshabad; Justin Wanek; Robert E Molokie; Roberto F Machado; Victor R Gordeuk; Mahnaz Shahidi
Journal:  Clin Case Rep       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.